A peer reviewed journal article highlighting the efficacy and safety of prabotulinumtoxinA (Jeuveau) for the treatment of moderate to severe glabellar lines, also known as frown lines between the eyes, in adult patients with Skin of Color (SOC), was published recently in Dermatologic Surgery, Evolus Inc announces in a media release.